Revolutionizing How the
World Treats Inflammation
So Humanity Can Thrive
Sen-Jam Pharmaceutical is focused on improving clinical outcomes for patients battling opioid use disorder, viral respiratory infections from coronaviruses such as COVID-19 and other painful inflammation and toxin-induced conditions, including arthritis, vaccinations, and even the infamous hangover. Using our patented proprietary technology and the accelerated 505(b)2 pathway, we are on a mission to revolutionize the way we treat pain, and the way the business of pain relief treats humanity.
Repurposing
Two Small Molecules
By taking two already proven to be both effective and safe molecular agents and ingenuously combining them, Sen-Jam has discovered a simple yet powerful product that very well may change the way the world views pain relief. Our patent portfolio is rich with global relevancy and our clinical studies, both executed and planned exhibit a modern ingenuity not common to our peers.
Reimagining
Partnerships
Our strategic partnerships run the full developmental spectrum and offer a refreshingly open model for partnerships to thrive and communities to benefit in multiple ways. From licensing to distribution and beyond, we embrace an entrepreneurial can-do spirit to transform the way healthcare connects commerce to caring.
Sen-Jam’s Head of Clinical Development speaking to hundreds of innovators and health transformers at the StartUp Health Festival during JP Morgan’s Health Conference in San Francisco, January 2019
people worldwide
have been infected by COVID-19
(as of March 2022)
of them died
The world was stopped in its tracks by the incredible impact from the global pandemic. The COVID-19 ripple effects brings with it the third and greatest economic, financial and social shock of the 21st century, after 9/11 and the global financial crisis of 2008. And the controversy around vaccines and treatments creates even more chaos than calm. That said, there is a very promising, common sense approach to treating coronavirus infections to help mitigate disease progression that so often harrowingly leads to lung damage. The time is now for a smarter more modern approach to treating this pandemic. We believe and science supports this fact, that the true culprit is runaway inflammation. Let’s tackle this issue once and for all.
The majority of treatments for COVID-19 today are anti-virals which come with
The cost for one of the more prominent Big Pharma coronavirus treatments exceeds
(SJP-002C hopes to be about a tenth of that cost)
ALCOHOL HANGOVER
Since the discovery of alcohol thousands of years ago, drinkers have enjoyed consuming alcoholic beverages but also suffer from the next-day negative effects of alcohol intake. This so-called alcohol hangover is defined as the combination of negative mental and physical symptoms which can be experienced after a single episode of alcohol consumption, starting when blood alcohol concentration (BAC) approaches zero. Alcohol Hangover refers to the cluster of symptoms, including headache, nausea, thirst, and fatigue, occurring immediately after much or all of the alcohol has left the body following heavy drinking. The causes of hangover are unknown although hypotheses have been reviewed and for Sen-Jam, the most obvious and promising root source is the inflammation that occurs with ingestion of alcohol.
the next day
workers
at work
due to hangover
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Putting an End to
The Opioid Crisis
Opioid Use Disorder is a problematic pattern of opioid use that leads to serious impairment or distress. It includes the use of prescription opoiods, heroin, or a combination of both. The intensity of withdrawal symptoms presents a significant barrier to abstinence and opioid dose reduction. Signs of chemical dependency are present within 5 days of opioid use.
SECONDS
MINUTES
overdoses
over 30K
deaths
annually
A tragedy that has killed more people annually than the AIDS crisis, Vietnam and automobile accidents combined.
It’s Time to Address This Head-on
Therapeutic Pipeline
Prescription Strength Relief
Over the Counter Relief
Prescription Strength
Over the Counter